0001637931-16-000003.txt : 20160331 0001637931-16-000003.hdr.sgml : 20160331 20160331135421 ACCESSION NUMBER: 0001637931-16-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160331 DATE AS OF CHANGE: 20160331 EFFECTIVENESS DATE: 20160331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Semma Therapeutics, Inc. CENTRAL INDEX KEY: 0001637931 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-237128 FILM NUMBER: 161542723 BUSINESS ADDRESS: STREET 1: 450 KENDALL STREET STREET 2: 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-901-4221 MAIL ADDRESS: STREET 1: 450 KENDALL STREET STREET 2: 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 D/A 1 primary_doc.xml X0707 D/A LIVE 0001637931 Semma Therapeutics, Inc. 450 KENDALL STREET STE 2B CAMBRIDGE MA MASSACHUSETTS 02142 857-529-6430 DELAWARE None None Corporation true 2014 Robert Millman 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Todd Foley 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Jim Scopa 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Director Stephen Knight 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Director Mitch Finer 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Director Kingsley Taft Exchange Place Boston MA MASSACHUSETTS 02109 Executive Officer William Sahlman 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b true 0001637931-15-000002 2015-03-19 true true false 0 25018073 15418075 9599998 Series A Preferred Stock false 10 0 0 0 false Semma Therapeutics, Inc. Robert Millman Robert Millman President 2016-03-31